AbbVie (ABBV) insider trading and SEC filings
AbbVie Inc. · NYSE · Pharmaceutical Preparations
Company facts
What AbbVie tells the SEC about itself on the same registration record these filings come from.
- Industry (SIC) — Pharmaceutical Preparations
- Exchange — NYSE
- Filer category — Large accelerated filer
- Fiscal year end — December 31
- State of incorporation — Delaware
ABBV insider transactions
Officers, directors and 10% owners must tell the SEC when they buy or sell AbbVie stock, within two business days. These are the most recent, straight from EDGAR.
I read the 8 insider filings below, filed between May 12 and Oct 2, 2026, all on Form 4. Each one is about AbbVie stock and links to the original on EDGAR. They name 6 insiders: 5 directors and 1 officer. Of the filings, 1 reports an open-market sale, 1 an option exercise, and 3 a grant or award (some filings report more than one type). In the 1 filing reporting a sale, the same person also reports an option exercise on the same trade date. AbbVie's SEC record shows its latest 10-K filed Feb 20, 2026, its latest 10-Q Aug 3, 2026, and its latest 8-K Oct 5, 2026.
| Form | Filed | Insider | Transaction | Price | Trade date | Shares held after | Ownership | |
|---|---|---|---|---|---|---|---|---|
| 4 | 2026-10-02 | Quaggin Susan E — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-10-02 | RAPP EDWARD J — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-08-18 | Nicholas Donoghoe — EVP, CHIEF BUS/STRAT OFFICER | Option exercise · 32,710 shares | $79.02 | Aug 14, 2026 | 107,140 | Direct | Filing |
| Open-market sale · 32,710 shares | $250.00 | Aug 14, 2026 | 74,430 | Direct | ||||
| 4 | 2026-07-02 | RAPP EDWARD J — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-07-02 | Quaggin Susan E — Director | not itemised — see the filing | — | — | — | — | Filing |
| 4 | 2026-05-12 | FALK THOMAS J — Director | Grant or award · 1,118 shares | — | May 8, 2026 | 2,321 | Direct | Filing |
| 4 | 2026-05-12 | WADDELL FREDERICK H — Director | Grant or award · 1,118 shares | — | May 8, 2026 | 30,076 | Direct | Filing |
| 4 | 2026-05-12 | Roberts Rebecca B — Director | Grant or award · 1,118 shares | — | May 8, 2026 | 14,846 | Direct | Filing |
Transaction wording follows the code on the filing itself — what each Form 4 code means. An option exercise or a tax withholding is not a market decision, and is not shown as one.
- Form 4 — An insider bought or sold company stock
Get ABBV's filings, read.
Other recent AbbVie filings
| Form | Filed | Document |
|---|---|---|
| 8-K | 2026-10-05 | 8-K |
| 8-K | 2026-09-03 | FORM 8-K |
| 8-K | 2026-08-18 | FORM 8-K |
| 8-K | 2026-08-05 | FORM 8-K |
| 10-Q | 2026-08-03 | 10-Q |
| 8-K | 2026-07-31 | 8-K |
| 8-K | 2026-07-06 | 8-K |
| 10-K | 2026-02-20 | 10-K |
Reading these accurately
A Form 4 records what happened, precisely and on the record — it has no field for why. A sale can be scheduled months in advance under a Rule 10b5-1 plan, and vesting and option exercises appear alongside open-market decisions. The fuller version is in what insider buying and selling actually signals; to look up any other company, use the insider filing tracker.
Insider filings for other companies
Companies filing in the same sector, and other names Pip tracks.